Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

• Main Authors: Chong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: BioMed Central 2016
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/127278
• Institution: National University of Singapore

10.1186/s12885-015-1191-3